Symposium international Hadrontherapy for Life (EN)
Discover the major advancements in hadron therapy and download the full report from the Hadrontherapy for Life symposium.
CYCLHAD est le premier centre français d’hadronthérapie multi-ions, combinant traitement et recherche en protonthérapie, carbone-thérapie et hélium-thérapie. Basé à Caen, le centre réunit des acteurs hospitaliers, académiques et industriels pour faire progresser la médecine de précision en oncologie. Retrouvez ici nos communiqués, dossiers et ressources presse.
Symposium international Hadrontherapy for Life (EN)
Discover the major advancements in hadron therapy and download the full report from the Hadrontherapy for Life symposium.
PROTON THERAPY : A PROMISING APPROACH FOR SKIN CANCERS
Explore the expanding role of particle therapy in managing primary and recurrent non-melanoma skin cancers (NMSC). In this exclusive webinar, leading experts fr...
MEDICO-ECONOMICS & NETWORKS IN HADRONTHERAPY
Particle therapy combines cutting-edge physics, biology, and clinical care to treat complex cancers. Beyond clinical outcomes, its economic, societal, and scien...
MEDICAL PHYSICS, INSTRUMENTATION & TECHNOLOGY IN HADRONTHERAPY
Hadrontherapy is at the forefront of precision oncology, combining advanced physics, engineering, and biology to treat cancer with unmatched accuracy. Innovatio...
RADIOBIOLOGY & CARCINOGENESIS OF PARTICLES
During the Hadrontherapy for Life symposium held in March 2025 in Caen, France, leading international experts outlined how particle therapy can overcome radiore...
Symposium international Hadrontherapy for Life (FR)
Découvrez les avancées majeures de la hadronthérapie et téléchargez le rapport complet du symposium Hadrontherapy for Life.
CLINICAL INDICATIONS IN CARBON-ION RADIOTHERAPY
During the Hadrontherapy for Life symposium held in March 2025 in Caen, France, leading international experts reviewed global carbon-ion and proton therapy prog...
KIT MEDIA / RESSOURCES
Télécharger la valise de logos
Les tournages et visites presse sont possibles sur demande et sous conditions de non-perturbation de l’activité clinique.